Should women have different ECG criteria for CRT than men?

Area of Science:

• Cardiology
• Medical Devices

Background:

• Cardiac resynchronization therapy (CRT) is a device therapy used in heart failure management.
• Clinical trials use QRS duration and morphology to assess left ventricular dyssynchrony, guiding CRT eligibility.
• Current guidelines are based on trials with underrepresentation of women.

Purpose of the Study:

• To review the evidence supporting CRT guidelines.
• To examine the differential benefits of CRT in women compared to men.
• To advocate for individualized CRT prescription, especially for women.

Main Methods:

• Review of existing clinical trials and studies on cardiac resynchronization therapy.
• Analysis of data regarding the efficacy of CRT in different patient populations, focusing on sex differences.
• Synthesis of evidence to inform current and future treatment guidelines.

Main Results:

• Despite underrepresentation in trials, women show statistically significant improvements in risk reduction with CRT compared to men.
• Evidence suggests women may gain more benefit from CRT than previously understood.
• Existing guidelines may not fully capture the potential advantages of CRT for female patients.

Conclusions:

• Current guidelines for CRT may need revision to account for sex-based differences in treatment response.
• Women may benefit more from cardiac resynchronization therapy than men.
• An individualized approach to prescribing CRT, particularly for women, is warranted.